Manuel Bicaj , Francesca Oliveri , Chiara Rossi , Andrea Rosano , Antonio Uccelli , Claudia Caponnetto , Pilar M. Ferraro
{"title":"Development of cognitive/behavioral disturbances in motor neuron diseases with pure motor onset: can we predict it?","authors":"Manuel Bicaj , Francesca Oliveri , Chiara Rossi , Andrea Rosano , Antonio Uccelli , Claudia Caponnetto , Pilar M. Ferraro","doi":"10.1016/j.jns.2025.123707","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Approximately 50 % of motor neuron disease (MND) patients manifest cognitive and/or behavioral impairment (C/BI). Notably, while some patients exhibit those disturbances from disease onset, others develop them during disease course, but the determinants of such phenomenon are still largely unknown.</div></div><div><h3>Objectives</h3><div>This study aimed at identifying baseline predictors of subsequent C/BI development in MNDs.</div></div><div><h3>Methods</h3><div>Pure motor MND cases with longitudinal Edinburgh Cognitive and Behavioral ALS screen (ECAS) exams were included (<em>N</em> = 80). Based on longitudinal data, patients were categorized as either remaining motor (“<em>non-converters</em>”, <em>N</em> = 55) or developing C/BI (“<em>converters</em>”, <em>N</em> = 25). Demographic, genetic, baseline motor and cognitive/behavioral features (with relative progression rates) were compared between groups using Mann-Whitney U and Chi-squared tests. Logistic regression models were used to identify significant predictors of C/BI development.</div></div><div><h3>Results</h3><div>Relative to <em>non-converters</em>, <em>converters</em> cases exhibited older age at symptoms onset/first visit (<em>p</em> = 0.02, <em>p</em> = 0.01), lower frequency of right limbs onset (<em>p</em> = 0.02), lower ECAS alternation (p = 0.01), spelling (p = 0.02) and fluency letter S (<em>p</em> = 0.05) scores, as well as higher alternation (<em>p</em> = 0.004) and spelling (<em>p</em> = 0.006) progression rates, albeit those contrasts did not survive correction for multiple comparisons. All variables except for the spelling score and progression rates were predictive of C/BI development (p from 0.002 to 0.03).</div></div><div><h3>Discussion</h3><div>While no firm conclusions can be drawn due to the lack of results surviving correction, our study suggests that specific clinical features significantly predict C/BI development in MNDs. These findings may facilitate an earlier identification of patients at risk for extra-motor symptoms development, enabling a more tailored clinical management.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"478 ","pages":"Article 123707"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X25003272","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Approximately 50 % of motor neuron disease (MND) patients manifest cognitive and/or behavioral impairment (C/BI). Notably, while some patients exhibit those disturbances from disease onset, others develop them during disease course, but the determinants of such phenomenon are still largely unknown.
Objectives
This study aimed at identifying baseline predictors of subsequent C/BI development in MNDs.
Methods
Pure motor MND cases with longitudinal Edinburgh Cognitive and Behavioral ALS screen (ECAS) exams were included (N = 80). Based on longitudinal data, patients were categorized as either remaining motor (“non-converters”, N = 55) or developing C/BI (“converters”, N = 25). Demographic, genetic, baseline motor and cognitive/behavioral features (with relative progression rates) were compared between groups using Mann-Whitney U and Chi-squared tests. Logistic regression models were used to identify significant predictors of C/BI development.
Results
Relative to non-converters, converters cases exhibited older age at symptoms onset/first visit (p = 0.02, p = 0.01), lower frequency of right limbs onset (p = 0.02), lower ECAS alternation (p = 0.01), spelling (p = 0.02) and fluency letter S (p = 0.05) scores, as well as higher alternation (p = 0.004) and spelling (p = 0.006) progression rates, albeit those contrasts did not survive correction for multiple comparisons. All variables except for the spelling score and progression rates were predictive of C/BI development (p from 0.002 to 0.03).
Discussion
While no firm conclusions can be drawn due to the lack of results surviving correction, our study suggests that specific clinical features significantly predict C/BI development in MNDs. These findings may facilitate an earlier identification of patients at risk for extra-motor symptoms development, enabling a more tailored clinical management.
期刊介绍:
The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials).
JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.